Chidamide, a subtype-selective histone deacetylase inhibitor, enhances Bortezomib effects in multiple myeloma therapy
Yanjuan He(Central South University), Fangping Chen(Central South University), Jiliang Xia(Central South University), Lang Zou(Army Medical University), Yajuan Cui(Central South University), Jingyu Zhang(North University of China), Yan Zhu(Shandong University), Kaixuan Zhang(Central South University), Yinghong Zhu(Ministry of Education of the People's Republic of China), Xuan Wu(Wuhan No.1 Hospital), Wen Zhou(Academy of Medical Sciences), Jian Hu(Central South University), Duanfeng Jiang(Central South University)
Cited by 10
Related Papers
Developing a Long Short-Term Memory (LSTM) based model for predicting water table depth in agricultural areas
|Journal of Hydrology|2018|824
NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers
|Cancer Cell|2013|302
Crop model improvement reduces the uncertainty of the response to temperature of multi-model ensembles
|Field Crops Research|2016|163
RETRACTED ARTICLE: Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11
|Journal of Nanobiotechnology|2022|113
Automated in-season mapping of winter wheat in China with training data generation and model transfer
|ISPRS Journal of Photogrammetry and Remote Sensing|2023|100